Introduction
The four-carbon non-protein amino acid, g-aminobutyric acid (GABA), is a major inhibitory neurotransmitter in the mammalian central nervous system [1] , as well as an important secondary metabolite involved in the plant and bacterial stress response [2] [3] [4] . GABA is metabolized through the pathway of 'GABA shunt' after being synthesized from glutamic acid by glutamic acid decarboxylase [5, 6] . The GABA transaminase converts GABA to succinic semialdehyde (SSA), and the SSA is further processed to succinic acid by succinic semialdehyde dehydrogenase (SSADH) [7, 8] . Succinic acid is then the final form of GABA to enter the tricarboxylic acid cycle. An alternative pathway of the GABA shunt is that SSA is converted by succinic semialdehyde reductase (SSAR, also named as g-hydroxybutyrate dehydrogenase) to g-hydroxybutyrate (GHB) [9, 10] , a natural compound in the brain and a recreational drug with its exact role unclear. In humans, the alternative pathway was demonstrated by the elevated GHB level detected in patients with autosomal deficiency of SSADH [11, 12] . While the GABA is accumulated to 3 fold in patients, the GHB is increased to 200 fold, and the increased GHB was thought to be converted from SSA by SSAR [13] [14] [15] . In plants, accumulated GHB detected in tissue may be in response to oxygen deficiency and the SSAR is probably involved in plant stress tolerance [4] . A recently identified SSAR from Arabidopsis was found to reduce both glyoxylate and SSA [2, 16, 17] . In bacteria, the alternative SSA metabolism pathway was also suggested, especially by a recently characterized SSAR from Escherichia coli [3] .
To explore the structural and functional relationship of SSAR, here, we identified SSARs from genomic sequences of Geobacter sulfurreducens and Geobacter metallireducens (denoted as GsSSAR and GmSSAR, respectively). The GsSSAR and GmSSAR were over-expressed in E. coli and purified. Preliminary activity assay showed that both enzymes use nicotinamide adenine dinucleotide phosphate (NADPH) as a co-factor. The GsSSAR and GmSSAR, which appear as tetramers in solution, were crystallized and the crystals diffracted to 1.89 and 2.25 Å , respectively, in the presence of NADP þ .
Materials and Methods
Reagents and bioinformatics resources Luria Broth (LB) media and isopropyl b-D-1-thiogalactopyranoside (IPTG) were purchased from Fisher Scientific
(Pittsburgh, USA), Ni-NTA affinity resin was from Qiagen Inc. (Valencia, USA) and the crystal screening kits were from Hampton Research (Aliso Viejo, USA) and Emerald BioSystems (Bainbridge Island, USA). Hitrap Q 1 ml ion exchange column was purchased from GE Healthcare (Piscataway, USA) and the ion exchange chromatography was performed on an AKTA FPLC system from GE Healthcare. All other chemicals were from Sigma Chemical Company (St Louis, USA). Protein sequence alignment was performed using online server TCoffee (http://tcoffee. vital-it.ch/) and the alignment was visualized by ESPript (http://espript.ibcp.fr).
DNA cloning, protein expression and purification
The cDNAs encoding for GsSSAR and GmSSAR were amplified from the Geobacter sulfurreducens and Geobacter metallireducens genomic DNA, respectively, by PCR. The PCR amplification consists of 35 cycles of denaturing steps at 948C for 30 s, annealing at 558C for 45 s, and elongation at 728C for 1 min followed by 728C for 10 min. The PCR products were purified by QIAquick PCR purification kit (Qiagen) and were digested by restriction enzymes AflIII/XhoI (GsSSAR) or BspHI/XhoI (GmSSAR). The expression vector, pLW01, digested by restriction enzymes NcoI (compatible with AflIII or BspHI) and XhoI together with the digested PCR products was transformed into E. coli DH5a competent cells. Positive clones growing from LB agar plates containing 100 mg/ml ampencillin were picked, and the plasmid DNAs were isolated and sequenced.
Constructed plasmids were then transformed into expression host E. coli BL21 (DE3) competent cells for protein expression. A fresh single colony was inoculated into 100 ml LB media containing 100 mg/ml ampicillin at 378C with shaking at 200 r.p.m. overnight. Then, 20 ml of this culture was transferred into 1 L fresh LB media and the cells were grown at 378C until the OD 600 reached to 0.8-1.0. The cells were then induced by adding 1 mM IPTG and incubated with shaking at 378C for 4 h. Cells were harvested by centrifugation and stored at -808C.
To purify the recombinant SSAR proteins, the cell pellets were re-suspended in Buffer A (50 mM NaH 2 PO 4 , 300 mM NaCl, 0.1 mM ethylenediaminetetraacetic acid, pH 8.0). After sonication, the crude cell extract was centrifuged at 48C for 20 min at 12,000 g. The supernatant was loaded onto a column containing 20 ml Ni-NTA agarose slurry. The column was washed with Buffer A containing 25 and 200 mM imidazole, respectively. Protein eluted from latter fractions were pooled and concentrated to 1 ml and loaded on a 1 ml HiTrap Q ion exchanger preequilibrated with 20 mM Tris-HCl, pH 8.5. Protein was eluted off the column with a linear concentration gradient of NaCl from 0 to 1 M, at a flow rate of 1 ml/min. The peak fractions containing highly purified target protein were pooled and concentrated.
Size exclusion chromatography
The oligomeric sizes of GsSSAR and GmSSAR were determined by size exclusion chromatography using a Superdex 200 10/30 GL column (GE Healthcare) pre-equilibrated with elution buffer (20 mM Tris-HCl, 200 mM NaCl, pH 8.0) under a flow rate of 0.5 ml/min. The effect of NADP þ binding on the oligomeric states of GsSSAR and GmSSAR was also investigated under the same conditions. Protein standards (Bio-Rad, Hercules, USA) thyroglobulin (670,000 Da), bovine g-globulin (158,000 Da), chicken ovalbumin (44,000 Da), equine myoglobin (17,000 Da), and vitamin B12 (1350 Da) were applied to the same column under the same conditions with those used for GsSSAR and GmSSAR. The standard curve was plotted as K av vs. known molecular weight. K av was obtained by the formula of
, where V e is the elution volume of each molecular weight markers, V o is the void volume, and V t is total volume of the column. The K av of GsSSAR and GmSSAR were used for estimating the protein size in solution with the standard curve.
Enzymatic activity measurement
The capability of GsSSAR and GmSSAR reducing SSA was evaluated at room temperature. NADH or NADPH was tested as a co-factor for the reaction and the decrease of absorbance at 340 nm was measured as an indicator of consumption of SSA. The reaction solution contains 50 mM Hepes, pH 7.5, 50 mM NaCl, 50 mM KCl, 0.3 mM NADH or NADPH, 4 mM SSA, and 50 mg GsSSA or GmSSA in a 3 ml volume. Absorbance at 340 nm was measured spectrophotometrically at different time points. All data points represent an average of at least three independent measurements.
Crystallization and preliminary data analysis Prior to crystallization, the protein buffers were exchanged to 20 mM Tris-HCl, 100 mM NaCl, pH 7.4, by spin columns containing Sephadex G-25 Coarse (GE Healthcare). In some of the crystallization experiments, NADP þ was added to protein solution up to a final concentration of 1 mM. Crystallization was achieved by mixing 2 ml protein solution with 2 ml reservoir solution in microbatch-under-oil and hanging-drop vapour diffusion setups. X-ray diffraction quality crystals of GsSSAR grew from conditions consisting of 14% PEG8000, 0.2 M sodium acetate, 0.1 M sodium cacodylate, pH 6.5, whereas GmSSAR crystals grew in 25% PEG4000, Tris-Maleate, pH 4.5. Crystals were stepwise transferred into cryoprotectant solutions containing increasing concentrations of glycerol, and then flash frozen and stored in liquid nitrogen.
Identification of GsSSAR and GmSSAR
X-ray diffraction data were collected at the ID-21-G beamline at LS-CAT (Advanced Photon Source, Argonne National Laboratory, Argonne, USA). Collected data were processed using DENZO, and integrated intensities were scaled using the SCALEPACK from the HKL-2000 program package [18] . Further data processing of the X-ray data was done using the CCP4 suite of programs [19] .
Results and Discussion
Protein expression, purification, and characterization The GsSSAR and GmSSAR were expressed in E. coli to a high level ( 30% of total cell protein) with excellent solubility ( 90% soluble). Initial protein purification by Ni-NTA affinity column yielded large amounts of purified 
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proteins with at least 90% pure judged by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) (Fig. 1) . Approximately 150-200 mg GsSSAR or GmSSAR was purified from 1 L cell culture at this stage. GsSSAR and GmSSAR have isoelectric points ( pI) of 5.6 and 5.8, respectively. Therefore, an anion exchange chromatography was used for further protein purification. GsSSAR and GmSSAR were eluted from the ion exchanger with single peaks at ionic strength of 0.20-0.25 M NaCl and 0.15-0.25 M NaCl, respectively [ Fig. 2(A,B) ]. Judged from SDS-PAGE, both proteins were purified to .98% pure [ Fig. 2(C,D) ]. About 100-150 mg GsSSAR or GmSSAR at near homogeneity level was obtained from 1 L cell culture after the ion exchange purification.
To test the ability of GsSSAR and GmSSAR to reduce SSA, an activity assay measuring the consumption of the putative enzyme co-factor, either NADH or NADPH, at absorbance of 340 nm (A 340 ) was performed. When NADH was tested as a co-factor, no obvious changes in A 340 were observed (data not shown), indicating NADH may not be a suitable cofactor for GsSSAR and GmSSAR. In contrast, when NADPH was tested, significant decrease in A 340 was found (Fig. 3) , indicating GsSSAR and GmSSAR consume NADPH. Although with 64% amino-acid sequence identity (Fig. 4) , the GsSSAR showed better activity reducing SSA than GmSSAR as the decreased A 340 measured with GsSSA was faster than that Figure 4 Primary sequence alignment between GsSSAR, GmSSAR, and SSAR from Arabidopsis thaliana (3DOJ) Protein sequences were aligned by using the online TCoffee server (http://tcoffee.vital-it.ch/); the alignment was visualized by ESPript (http://espript.ibcp.fr). Conserved residues are shielded. The numbering on top of the alignment is according to the protein sequence of GsSSAR.
Figure 3 Activity of GsSSAR and GmSSAR
The decreased absorbance at 340 nm was measured when SSA and NADPH were used as a substrate and a co-factor, respectively. A solution containing only NADPH and reaction buffer but no proteins was used as a control. All data points represent the average of three independent measurements. (Fig. 3) . Preliminary data showed that the specific activities of GsSSAR and GmSSAR are 62.7 and 25.9 mM NADPH consumption per second per mg enzyme, respectively. These results confirmed that the GsSSAR and GmSSAR are capable of reducing SSA and demonstrated that NADPH/ NADP þ is the suitable co-factor for these enzymes. At this point, we have not yet been able to characterize the ability of GsSSAR and GmSSAR to catalyze the reverse reaction, converting GHB to SSA, as GHB is a licensed Schedule III controlled substance in the USA. However, further comprehensive characterization and kinetics study of the activities of GsSSAR and GmSSAR reducing SSA and other putative substrates are in progress. The oligomeric sizes of GsSSAR and GmSSAR were determined by analytical size exclusion chromatography. Both GsSSAR and GmSSAR eluted from a Superdex 200 column as a single peak at a size of 120 kDa [ Fig. 5(A,B) ], indicating the enzymes presumably exist as tetramers in solution (the molecular weight of the monomeric forms of GsSSAR and GmSSAR plus 6Âhis tag are 30.27 and 30.69 kDa, respectively). The potential effect of NADP þ binding on the oligomeric states of GsSSAR and
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GmSSAR was also evaluated. After incubating with Identification of GsSSAR and GmSSAR NADP þ , the enzymes showed no significant changes in the elution profiles [ Fig. 5(C,D) ], indicating that NADP þ has no obvious effect on the proteins' oligomeric states.
Crystallization and preliminary crystallographic analysis The initial crystallization screening of GsSSAR and GmSSAR were carried out with commercial crystallization kits to identify potential crystal growth in microbatch-under-oil and hanging-drop vapour diffusion formats. While no crystals were obtained for GmSSAR apo-enzyme, initial crystallization screening of GsSSAR apo-enzyme yielded crystals from quite a few conditions. However, best diffraction from crystals of the GsSSAR apo-enzyme extended only to 8 Å , which is not suitable for further structural analysis. The putative co-factor for GsSSAR and GmSSAR, NADP þ , was then added to protein solution at 1 mM concentration prior to further crystallization screening. In the presence of NADP þ , the GsSSAR readily crystallized in 14% PEG8000, 0.2 M NaAC, 0.1 M sodium cacodylate, pH 6.5 [ Fig. 6(A) ], regardless of the crystallization method used, and the crystals diffracted to 1.89 Å resolution. Meanwhile, the GmSSAR crystallized only using the microbatch method at a condition of 25% PEG4000, Tris-Maleate, pH 4.5 [ Fig. 6(B) ]; GmSSAR crystals diffracted to 2.25 Å resolution.
The space group for the GsSSAR crystals was determined to be P2 1 . A self-rotation function revealed the existence of two independent sets of three perpendicular molecular 2-fold axes, suggesting the existence of two GmSSAR tetramers in the unit cell. The detailed X-ray diffraction data-collection statistics is summarized in Table 1 . Since the size exclusion chromatography results suggested that the GsSSAR and GmSSAR are tetramers in solution, we are investigating whether these enzymes assume other oligomeric states in the crystals due to crystallographic symmetry and/or noncrystallographic symmetry. A BLAST search of the protein structures in the Protein Data Bank (http://www.rcsb.org/) revealed a close SSAR homolog from Arabidopsis thaliana (PDB code 3DOJ) that may be suitable for molecular replacement phasing (Fig. 4) . Initial molecular replacement trials have given promising potential solutions for both the GsSSAR and GmSSAR crystals. Refinement of these molecular replacement solutions is underway. Identification of GsSSAR and GmSSAR
